/ /

Oncology

Update on advanced basal cell carcinoma diagnosis and treatmentDespite increased insight on skin cancer risk factors, the incidence continues to rise worldwide. This review article summarizes new treatment options available, which help to redefine and expand the diagnosis of advanced BCC and allow dermatologists to offer more effective therapy to a broader population.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy.
Staying current with therapeutic advances and expert insightsThis month we offer new insights and data to aid diagnosis and treatment of difficult conditions, as well as practical approaches to optimize outcomes.
CeraVe sun protection products earn recommendation sealsCeraVe AM Facial Moisturizing Lotion SPF 30 and CeraVe Sunscreen SPF 50 for Face (both by Valeant Pharmaceuticals) have been awarded Skin Cancer Foundation seals.
Best practices for treating severe sun damageThe goal of treatment for severely sun-damaged patients’ lesions is field therapy, which not only treats what dermatologists see, but also subclinical disease.
Vismodegib study confirms safety, efficacy for BCCThe largest-ever vismodegib study in advanced basal cell carcinoma, the STEVIE study, confirms pivotal study findings in a real-world setting, helping dermatologists to provide a complete palette of skin cancer treatments.
New target could predict melanomaNew information could eventually help identify a high-risk population before they get cancer — even prevent skin cancer’s onset.
First do no Mohs harmAn expert advises evaluating each patient’s surrounding circumstances when determining whether Mohs surgery is indicated.
How to weigh benefit of Moh'sMohs surgery experts advise when Mohs is and isn’t optimal skin cancer treatment.
Improving accuracy in NMSC diagnosisThe trend toward smaller biopsies may compromise the accuracy of dermatopathologists' diagnoses.

Poll

View Results